Belly dancer syndrome improved by withdrawal of droxidopa and amantadine

Abstract

Key Clinical Message A man hospitalized for cerebral infarction developed drug‐induced belly dancer syndrome, which improved after withdrawal of droxidopa and amantadine. Drugs that modulate dopamine neurotransmission have been reported to be associated with this syndrome. When belly dancer syndrome is suspected, clinicians should consider drug‐induced abdominal dyskinesia and medication withdrawal.

Keywords

• abdominal wall
• amantadine
• dopamine
• droxidopa
• dyskinesia
• movement disorders